发布: 2016年10月05日第6卷第19期 DOI: 10.21769/BioProtoc.1956 浏览次数: 14099
评审: HongLok LungShravani MukherjeeAnonymous reviewer(s)
相关实验方案
来自骨髓增生性肿瘤患者的造血祖细胞的血小板生成素不依赖性巨核细胞分化
Chloe A. L. Thompson-Peach [...] Daniel Thomas
2023年01月20日 1464 阅读
Abstract
HER2 is a tyrosine kinase receptor, which is overexpressed in about 30% of breast cancer patients. Its overexpression leads to mammary tumorigenesis and increased invasion and metastasis (Slamon et al., 1987). HER2 transgenic mouse (FVB/N-MMTVneu mouse) is a well-established model of mammary tumor in human (Fantozzi and Christofori, 2006). Although in vivo models are excellent for assessing the influence of various factors, especially microenvironment, on development of breast cancer, a convenient and less costly way to study the underlying molecular events is utilizing cells derived from the model under evaluation. In order to explore the molecular mechanism by which HOXB7 inhibits initiation, but promotes metastasis of breast tumors, we generated mouse breast cancer cell line from HER2 transgenic mouse (Liu et al., 2015). This protocol may be useful for the generation of breast cancer cell line from mice with other genetic backgrounds.
Keywords: HER2 Transgenic mice (HER2基因的转基因小鼠)Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2016 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Liu, S. and Chen, H. (2016). Isolation of Primary Breast Cancer Cells from HER2 Transgenic Mice. Bio-protocol 6(19): e1956. DOI: 10.21769/BioProtoc.1956.
分类
癌症生物学 > 癌症干细胞 > 细胞生物学试验
细胞生物学 > 细胞分离和培养 > 细胞分离
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link